Evidence map›Paper›PMID 38867194›Full record

ArticleBMC oral health2024

Hyaluronic acid as a pulpotomy material in primary molars: an up to 30 months retrospective study.

Batın Ilgıt Sezgin, Gökce Cicek Ildes Sezgin, Özge Koyuncu, Ali Mentes

Registry-linked trialAbstract readComparative Study
In one paragraph

Article in BMC oral health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07168811 (Comparative Clinical and Radiographic Evaluation of Hyaluronic Acid, TheraCal, and Mineral Trioxide Aggregate as Pulpotomy Agents in Primary Molars), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07168811 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Comparative Clinical and Radiographic Evaluation of Hyaluronic Acid, TheraCal, and Mineral Trioxide Aggregate as Pulpotomy Agents in Primary Molars: A Randomized Clinical Trial

TypeinterventionalSponsorAl-Azhar UniversityRan2025 to 2026Enrolled66ConditionsPulpotomies Primary Teeth, Pulp Disease, DentalArmsHyaluronic Acid (HA), TheraCal, Mineral Trioxide Aggregate
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Batın Ilgıt SezginDepartment of Paediatric Dentistry, Faculty of Dentistry, Istanbul Galata University, Istanbul, Türkiye, 34430, Turkey. batinilgit@gmail.com.ORCID http://orcid.org/0000-0001-9578-9611
Gökce Cicek Ildes Sezgin, Private practice, Istanbul, Türkiye, 34843, Turkey.ORCID http://orcid.org/0000-0002-5728-4476
Özge KoyuncuDepartment of Paediatric Dentistry, Faculty of Dentistry, Marmara University, Istanbul, Türkiye, 34854, Turkey.ORCID http://orcid.org/0009-0006-6093-0682
Ali MentesDepartment of Paediatric Dentistry, Faculty of Dentistry, Marmara University, Istanbul, Türkiye, 34854, Turkey.ORCID http://orcid.org/0000-0002-2778-6803

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this retrospective study was to determine the long-term clinical and radiographic success of our previous randomized clinical trial and to compare the success of hyaluronic acid, with the widely used formocresol and ferric sulphate agents.

methodsThis retrospective study is the extension of the 1-year survey of our randomized clinical trial that had compared the effectiveness of a hyaluronic acid pulpotomy over formocresol and ferric sulphate pulpotomies and included clinical and radiographic evaluations with a follow-up period of over 24 months for 44 children who applied to our clinic between May 2019 and September 2019. Long-term clinical and radiographic data were obtained from the periodic files of our department, wherein each tooth's file was examined to identify any clinical and radiographic findings. Descriptive statistics and Pearson's chi-square tests were used to evaluate the data. Statistical significance was considered as p < 0.05.

resultsThe clinical and radiographic success rates of the hyaluronic acid, formocresol, and ferric sulphate groups were not statistically different at > 24 months. None of the teeth in the hyaluronic acid group showed any clinical findings at > 24 months.

conclusionsHyaluronic acid pulpotomies exhibited comparable success rates to formocresol and ferric sulphate materials spanning over 24 months examinations. Because of convenient accessibility and applicability of hyaluronic acid, it may be recommended as a promising alternative medicament for pulpotomy treatments of primary molars. However, further long-term follow-up human studies are needed to better understand the effect of hyaluronic acid on the dental pulp of human primary molars.

Indexed as

Adjuvants, ImmunologicHyaluronic AcidMolarPulpotomyTooth, DeciduousChildChild, PreschoolFemaleFerric CompoundsFormocresolsHumansMaleRadiography, DentalRandomized Controlled Trials as TopicRetrospective StudiesAdjuvants, ImmunologicFerric Compoundsferric sulfateformocresolFormocresolsHyaluronic AcidFerric sulphateFormocresolHyaluronic acidPrimary molarsPulpotomyRetrospective study

Identifiers

PMID38867194
PMCPMC11167839

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.